Sacubitril/Valsartan for the Prevention and Treatment of Postinfarction Heart Failure: Ready to Use?

被引：1
|
作者：
Del Buono, Marco G. [1 ,2 ]
Damonte, Juan, I [1 ,3 ]
Trankle, Cory R. [1 ]
Bhardwaj, Hem [1 ]
Markley, Roshanak [1 ]
Turlington, Jeremy [1 ]
Van Tassell, Benjamin W. [1 ,4 ]
Salloum, Fadi N. [1 ]
Abbate, Antonio [1 ]
机构：
[1] Virginia Commonwealth Univ, Pauley Heart Ctr, Div Cardiol, Dept Internal Med, Richmond, VA 23298 USA
[2] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Thorac Sci, Rome, Italy
[3] Hosp Italiano Buenos Aires, Dept Hemodynam & Intervent Cardiol, Buenos Aires, DF, Argentina
[4] Virginia Commonwealth Univ, Sch Pharm, Richmond, VA 23298 USA
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2021年 / 78卷 / 03期
关键词：
ACUTE MYOCARDIAL-INFARCTION; CLINICAL-EVIDENCE; MORTALITY; MORBIDITY; SURVIVORS; RAMIPRIL;
D O I：
10.1097/FJC.0000000000001103
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：331 / 333
页数：3
相关论文
共 50 条
  • [41] Reply: Sacubitril/valsartan for Chagas' heart disease heart failure?
    Bocchi, Edimar Alcides
    Rassi, Salvador
    Guimaraes, Guilherme Veiga
    ESC HEART FAILURE, 2018, 5 (06): : 1072 - 1073
  • [42] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Rex C. Liu
    American Journal of Cardiovascular Drugs, 2018, 18 : 473 - 482
  • [43] Economic evaluation of sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction
    Stafylas, P.
    Farmakis, D.
    Giamouzis, G.
    Hatzikou, M.
    Kourlaba, G.
    Papatsouma, I.
    Maniadakis, N.
    EUROPEAN HEART JOURNAL, 2016, 37 : 730 - 731
  • [44] Sacubitril/Valsartan in the primary treatment of heart failure with reduced ejection fraction (HFrEF)
    Nowak, Bernd
    Geiss, Ernst
    Boehm, Michael
    Weil, Joachim
    Boer, Jana
    KARDIOLOGIE, 2023, : 44 - 48
  • [45] Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
    Abumayyaleh, Mohammad
    El-Battrawy, Ibrahim
    Behnes, Michael
    Borggrefe, Martin
    Akin, Ibrahim
    FUTURE CARDIOLOGY, 2020, 16 (04) : 227 - 236
  • [46] Clinical Efficacy of Metoprolol Combined with Sacubitril/Valsartan in the Treatment of Chronic Heart Failure
    Zhao, Yubao
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 41 - 46
  • [47] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Liu, Rex C.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (06) : 473 - 482
  • [48] The Risk for Sudden Cardiac Death and Effect of Treatment With Sacubitril/Valsartan in Heart Failure
    El-Battrawy, Ibrahim
    Borggrefe, Martin
    Akin, Ibrahim
    JACC-HEART FAILURE, 2019, 7 (11) : 999 - 999
  • [49] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF HEART FAILURE IN COSTA RICA
    Lacey, M. J.
    Brouillette, M.
    Lenhart, G.
    Hernandez Matamoros, H.
    Quesada Chaves, D. F.
    Bonilla Sinibaldi, F.
    Russell, M. W.
    VALUE IN HEALTH, 2018, 21 : S60 - S60
  • [50] ASSOCIATION OF HEART FAILURE PATIENTS WITH AND WITHOUT SACUBITRIL-VALSARTAN USE WITH INCIDENT CANCER RISK -REFINE THE ROLE OF SACUBITRIL-VALSARTAN
    Hu, W.
    ATHEROSCLEROSIS, 2023, 379 : S87 - S87
12345